Clinical Trials Directory

Trials / Completed

CompletedNCT03509714

Oxaloacetate Supplementation for Emotional PMS

Oxaloacetate Supplementation for Emotional PMS; Measuring Improvements in Depression, Anxiety, Perceived Stress, and Aggression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Terra Biological LLC · Industry
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Emotional Premenstrual Syndrome (PMS) affects millions of women worldwide. For Emotional PMS, including depression, anxiety, perceived stress and aggression, there are very few options. Recent observational data suggest that nutritional supplementation with oxaloacetate, a human energy metabolite, greatly reduced the symptoms of Emotional PMS. The aim of this study was to confirm these observations on the effects of oxaloacetate on Emotional PMS symptom severity within a controlled clinical trial setting.

Detailed description

Oxaloacetate is an energy metabolite found in every cell of the human body. It holds a key place in the Krebs Cycle within the mitochondria, providing energy to the cells. It is also a critical early metabolite in gluconeogenesis, which provides glucose for the heart and brain during times of low glucose. It is critical to human metabolism, proper cellular function and it is central to energy production and use in the body. Oxaloacetate may affect Emotional PMS through multiple mechanisms. During PMS, there is a large increase in glucose utilization in the cerebellum of the brain in women who are affected with emotional mood swings. Oxaloacetate supplementation has been shown to support proper glucose levels in the body. Having an excess of oxaloacetate allows gluconeogenesis take place upon demand, thereby fueling the brain, and perhaps meeting cerebellum glucose need. In addition to oxaloacetate's ability to support proper glucose regulation, oxaloacetate affects two chemicals in the brain, GABA and glutamate. Altering the GABA/Glutamate ratio can affect mood. Oxaloacetate supplementation can reduce glutamate levels in the brain via a process called "Glutamate Scavenging". In addition, oxaloacetate supplementation was shown to increase GABA levels in animal models. By both lowering glutamate and increasing GABA, the GABA/Glutamate ratio is affected, which may also help women with Emotional PMS. This study will investigate oxaloacetate's effect on Emotional PMS using patient completed surveys to measure depression, anxiety, perceived stress, and aggression, and statistically compare these results against placebo (rice flour) and baseline measurements.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTJubilance (100 mg Oxaloacetate/150 mg Ascorbic Acid)2 Pills to be taken orally per day during their entire menstrual cycle
DIETARY_SUPPLEMENTrice flour (Placebo)250 mg rice flour (Placebo)

Timeline

Start date
2016-10-17
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2018-04-26
Last updated
2018-04-26

Source: ClinicalTrials.gov record NCT03509714. Inclusion in this directory is not an endorsement.

Oxaloacetate Supplementation for Emotional PMS (NCT03509714) · Clinical Trials Directory